STOCK TITAN

Andreas Bovopoulos holds 4.32M Cosmos Health (COSM) shares — Schedule 13G/A

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Cosmos Health Inc. Amendment No. 4 reports that Andreas Bovopoulos beneficially owns 4,324,197.22 shares of Common Stock, representing 7.212% of the class, with sole voting and dispositive power. The filing is dated 06/05/2026 and lists the holding on an amended Schedule 13G/A.

Positive

  • None.

Negative

  • None.

Insights

Major passive stake disclosed: beneficial ownership of 4.32M shares (7.212%).

The filing shows Andreas Bovopoulos holds 4,324,197.22 shares with sole voting and dispositive power as reported on 06/05/2026. This is an amended Schedule 13G/A, indicating an update to a previously reported passive ownership statement.

Holder intentions are not stated in the excerpt; subsequent filings would indicate any change in status or plans.

Filing is a compliance disclosure of beneficial ownership under Schedule 13G/A.

The statement lists sole voting and dispositive power over 4,324,197.22 shares (7.212%), with the issuer address provided. The amendment label suggests prior filings were updated rather than a new acquisition disclosed here.

Cash‑flow treatment and transaction details are not provided in the excerpt; regulatory timing and any required further amendments depend on future changes in ownership or filing status.

Beneficial ownership 4,324,197.22 shares Schedule 13G/A amendment dated <date>06/05/2026</date>
Percent of class 7.212% Reported percent of outstanding common stock
Sole voting power 4,324,197.22 shares Amount with sole power to vote
Sole dispositive power 4,324,197.22 shares Amount with sole power to dispose
Filing date 06/05/2026 Signature date on the amendment
Schedule 13G/A regulatory
"Amendment No. 4 to a Schedule 13G/A reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficially owned regulatory
"Amount beneficially owned: 4,324,197.22 in the ownership section"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 4,324,197.22"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the Schedule 13G/A for COSM disclose?

It discloses that Andreas Bovopoulos beneficially owns 4,324,197.22 shares of Cosmos Health common stock. The filing reports a 7.212% ownership stake and indicates sole voting and dispositive power as of 06/05/2026.

Does the filing show who controls voting and disposal of the shares?

Yes. The filing states the reporting person has sole voting power and sole dispositive power over 4,324,197.22 shares. No shared voting or dispositive power is reported in the excerpt.

Is this a new purchase or an amended disclosure for COSM?

This is an amendment — labeled Amendment No. 4 to a Schedule 13G/A — updating a previously filed passive ownership statement. The excerpt does not describe the underlying transaction or timing of acquisition.

What percentage of Cosmos Health does this ownership represent?

The filing reports the stake as 7.212% of the class. The percentage is tied directly to the reported 4,324,197.22 shares in the Schedule 13G/A dated 06/05/2026.

Does the filing indicate any planned sale or acquisition activity?

No. The excerpt provides beneficial ownership details and voting/dispositive power but does not state any planned sales, purchases, or intent to change the position.





221413206

(CUSIP Number)
06/05/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Bovopoulos Andreas
Signature:Andreas Bovopoulos
Name/Title:Individual Investor
Date:06/05/2026